NCT04928716View on ClinicalTrials.gov

Multiple Sclerosis and Voiding Symptoms: How to Assess?

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Multiple SclerosisLower Urinary Tract SymptomsVoiding Disorders
Interventions
OTHER

voiding phase evaluation

Assessment of voiding phase in multiple sclerosis patients

Trial Locations (1)

75020

Department of Neuro- Urology, Hôpital Tenon, Paris

All Listed Sponsors
lead

Pierre and Marie Curie University

OTHER

NCT04928716 - Multiple Sclerosis and Voiding Symptoms: How to Assess? | Biotech Hunter | Biotech Hunter